SCHEMBL28443283

SCHEMBL28443283

NC(CC(=O)O)C(=O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.41
GRIK1 P39086 5/20 0.41
GRIK2 Q13002 3/20 0.41
GRM1 Q13255 2/20 0.41
GRM2 Q14416 2/20 0.41
GABRR1 P24046 2/20 0.40
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
GRIA4 P48058 2/20 0.39
GRIK3 Q13003 2/20 0.39
GRIK5 Q16478 2/20 0.39
GRM8 O00222 1/20 0.39
GRM6 O15303 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GSR P00390 1/20 0.39
CYP1A2 P05177 1/20 0.39
GRM5 P41594 1/20 0.39
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1245907 1.00 SLC22A6 (0.41) SLC22A6GRIK1GRIK2GRM1GRM2
SCHEMBL17921870 0.88 SLC22A6 (0.45) SLC22A6GRIK1GRIK2GRM1GRM2
SCHEMBL4161257 0.83 SLC22A6 (0.41) SLC22A6GRIK1GRIK2GRM1GRM2
SCHEMBL16138447 0.79 ALOX15 (0.39) SLC22A6GRIK1GRIK2GRM1GRM2
SCHEMBL3183276 0.79 GRIK1 (0.45) SLC22A6GRIK1GRIK2GRM1GRM2
SCHEMBL8520307 0.79 GRIK1 (0.43) SLC22A6GRIK1GRIK2GRM1GRM2
SCHEMBL7407055 0.79 GRIK1 (0.40) SLC22A6GRIK1GRIK2GRM1GRM2
SCHEMBL17636172 0.79 GABRR1 (0.42) SLC22A6GRIK1GRIK2GRM1GRM2
SCHEMBL7407058 0.79 GRIK1 (0.40) SLC22A6GRIK1GRIK2GRM1GRM2
SCHEMBL7733980 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117120449-A Combination therapy for cancer treatment 医睿世康药业研发公司 2023-11-24 CN disclosed
CN-117098537-A Combination therapy for cancer treatment 医睿世康药业研发公司 2023-11-21 CN disclosed
CN-117083283-A Combination therapy for cancer treatment 医睿世康药业研发公司 2023-11-17 CN disclosed
CN-114373510-A Metabolic marker for lung cancer diagnosis or monitoring and screening method and application thereof 武汉迈特维尔生物科技有限公司 2022-04-19 CN disclosed
CN-111505189-A Method for establishing influence of amoxicillin concentration on lactobacillus acidophilus based on metabonomics 广西医科大学 2020-08-07 CN disclosed